Issue 22, 2019

Bioimprint aided cell recognition and depletion of human leukemic HL60 cells from peripheral blood

Abstract

We report a large scale preparation of bioimprints of layers of cultured human leukemic HL60 cells which can perform cell shape and size recognition from a mixture with peripheral blood mononuclear cells (PBMCs). We demonstrate that the bioimprint-cell attraction combined with surface modification and flow rate control allows depletion of the HL60 cells from peripheral blood which can be used for development of alternative therapies of acute myeloid leukaemia (AML).

Graphical abstract: Bioimprint aided cell recognition and depletion of human leukemic HL60 cells from peripheral blood

Supplementary files

Article information

Article type
Communication
Submitted
08 Apr 2019
Accepted
25 Apr 2019
First published
07 May 2019

J. Mater. Chem. B, 2019,7, 3497-3504

Bioimprint aided cell recognition and depletion of human leukemic HL60 cells from peripheral blood

A. A.K. Das, J. Medlock, H. Liang, D. Nees, D. J. Allsup, L. A. Madden and V. N. Paunov, J. Mater. Chem. B, 2019, 7, 3497 DOI: 10.1039/C9TB00679F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements